Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 3Thoracic 1Sarcoma 1Other solid neoplasm 1Other neoplasm 1Other hematologic neoplasm 1Lymphoid 1Gynecologic 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Ovarian Neoplasms 1Breast Neoplasms 1

Interventions

Paclitaxel 140pembrolizumab 119Carboplatin 104Bevacizumab 92Cisplatin 67Specimen Handling 63Magnetic Resonance Spectroscopy 52olaparib 51Gemcitabine 39Nivolumab 36Biopsy 36liposomal doxorubicin 32Taxes 31Cyclophosphamide 31Blood Specimen Collection 29niraparib 27lenvatinib 26Doxorubicin 26Topotecan 25Letrozole 25Drug Therapy 25Immunoglobulin G 22fludarabine 21atezolizumab 21Radiotherapy 21Brachytherapy 21durvalumab 20Surveys and Questionnaires 20Disulfides 20dostarlimab 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Psilocybin × Gynecologic × 1 year × Clear all
NCT06430541 2026-04-21

Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence

University of Colorado, Denver

Phase 1 Recruiting
20 enrolled
BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡